Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 May 14:7:20220025.
doi: 10.2490/prm.20220025. eCollection 2022.

Pharmacotherapy and the Role of Pharmacists in Rehabilitation Medicine

Affiliations
Review

Pharmacotherapy and the Role of Pharmacists in Rehabilitation Medicine

Yoshihiro Yoshimura et al. Prog Rehabil Med. .

Abstract

Pharmacotherapy is important in older patients undergoing rehabilitation because such patients, especially those with frailty and physical disabilities, are susceptible to drug-related functional impairment. Drug-related problems include polypharmacy, potentially inappropriate medications (PIMs), and potential prescription omissions. These problems are associated with adverse drug events such as dysphagia, depression, drowsiness, falls and fractures, incontinence, decreased appetite, and Parkinson's syndrome, leading to impaired improvement in activities of daily living (ADL), quality of life (QOL), and nutritional status. Moreover, the anticholinergic burden is associated with impaired physical and cognitive functions. Therefore, pharmacist-centered multidisciplinary pharmacotherapy should be performed to maximize rehabilitation outcomes. Pharmacotherapy includes a review of all medications, the assessment of drug-related problems, goal setting, correction of polypharmacy and PIMs, monitoring of drug prescriptions, and reassessment of drug-related problems. The goal of pharmacotherapy in rehabilitation medicine is to optimize drug prescribing and to maximize the improvement of ADL and QOL as patient outcomes. The role of pharmacists during rehabilitation is to treat patients as part of multidisciplinary teams and as key members of nutritional support teams. In this review, we aim to highlight existing evidence regarding pharmacotherapy in older adults, including drug-related functional impairment and the association between pharmacotherapy and functional, cognitive, and nutritional outcomes among patients undergoing rehabilitation. In addition, we highlight the important role of pharmacists in maximizing improvements in rehabilitation outcomes and minimizing drug-related adverse effects.

Keywords: activities of daily living; convalescent rehabilitation; polypharmacy; potentially inappropriate medications; rehabilitation pharmacotherapy.

PubMed Disclaimer

Conflict of interest statement

CONFLICTS OF INTEREST: The authors report no conflicts of interest.

Figures

Fig. 1.
Fig. 1.
Pharmacist-centered multidisciplinary rehabilitation pharmacotherapy, drug-related functional impairment, and the association between pharmacotherapy and ADL, QOL, and nutritional outcomes in rehabilitation medicine. ADL, activities of daily living; QOL, quality of life; PIMs, potentially inappropriate medications; PPOs, potential prescribing omissions.

Similar articles

Cited by

References

    1. Onder G,Marengoni A: Polypharmacy. JAMA 2017;318:1728. 10.1001/jama.2017.15764 - DOI - PubMed
    1. Calderón-Larrañaga A,Poblador-Plou B,González-Rubio F,Gimeno-Feliu LA,Abad-Díez JM,Prados-Torres A: Multimorbidity, polypharmacy, referrals, and adverse drug events: are we doing things well? Br J Gen Pract 2012;62:e821–e826. 10.3399/bjgp12X659295 - DOI - PMC - PubMed
    1. Fried TR,O’Leary J,Towle V,Goldstein MK,Trentalange M,Martin DK: Health outcomes associated with polypharmacy in community-dwelling older adults: a systematic review. J Am Geriatr Soc 2014;62:2261–2272. 10.1111/jgs.13153 - DOI - PMC - PubMed
    1. Motter FR,Fritzen JS,Hilmer SN,Paniz ÉV,Paniz VM: Potentially inappropriate medication in the elderly: a systematic review of validated explicit criteria. Eur J Clin Pharmacol 2018;74:679–700. 10.1007/s00228-018-2446-0 - DOI - PubMed
    1. Hamilton H,Gallagher P,Ryan C,Byrne S,O’Mahony D: Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients. Arch Intern Med 2011;171:1013–1019. 10.1001/archinternmed.2011.215 - DOI - PubMed